Therapeutic strategies for endothelial dysfunction

Bibliography

• Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-74
   PubMed Web of Science ®Google Scholar
• Egashira K. Clinical importance of endothelial function in arteriosclerosis and ischemic heart disease. Circ J 2002;66:529-33
   PubMed Web of Science ®Google Scholar
• Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrol 2004;15:1983-92
   PubMed Web of Science ®Google Scholar
• Venkatachalam S, Gray BH, Mukherjee D, Shishehbor MH. Contemporary management of concomitant carotid and coronary artery disease. Heart 2011;97:175-80
   PubMed Web of Science ®Google Scholar
• Butt M, Dwivedi G, Blann A, Endothelial dysfunction: methods of assessment & implications for cardiovascular diseases. Curr Pharm Des 2010;16:3442-54
   PubMed Web of Science ®Google Scholar
• Flammer AJ, Luscher TF. Human endothelial dysfunction: EDRFs. Pflugers Arch 2010;459:1005-13
   PubMed Web of Science ®Google Scholar
• Tziomalos K, Athyros VG, Karagiannis A, Mikhailidis DP. Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management. Nutr Metab Cardiovasc Dis 2010;20:140-6
   PubMed Web of Science ®Google Scholar
• Sawabe M. Vascular aging: from molecular mechanism to clinical significance. Geriatr Gerontol Int 2010;10(Suppl 1):S213-20
   Google Scholar
• van den Heuvel M, Sorop O, van Beusekom HM, van der Giessen WJ. Endothelial dysfunction after drug eluting stent implantation. Minerva Cardioangiol 2009;57:629-43
   PubMedGoogle Scholar
• Mobius-Winkler S, Linke A, Adams V, How to improve endothelial repair mechanisms: the lifestyle approach. Expert Rev Cardiovasc Ther 2010;8:573-80
   PubMedGoogle Scholar
• Feletou M. The endothelium: part 1: multiple functions of the endothelial cells - focus on endothelium-derived vasoactive mediators. In: Granger ND, Granger JP, editors. Colloquium series on integrated systems physiology: from molecule to function to disease. Morgan & Claypool Life Sciences Publishers; San Rafael (CA): 2011
   Google Scholar
• Feletou M, Kohler R, Vanhoutte PM. Endothelium-derived vasoactive factors and hypertension: possible roles in pathogenesis and as treatment targets. Curr Hypertens Rep 2010;12:267-75
   PubMed Web of Science ®Google Scholar
• Feletou M, Vanhoutte PM. EDHF: an update. Clin Sci (Lond) 2009;117:139-55
   PubMed Web of Science ®Google Scholar
• Edwards G, Feletou M, Weston AH. Endothelium-derived hyperpolarising factors and associated pathways: a synopsis. Pflugers Arch 2010;459:863-79
   PubMed Web of Science ®Google Scholar
• Virdis A, Ghiadoni L, Taddei S. Human endothelial dysfunction: EDCFs. Pflugers Arch 2010;459:1015-23
   PubMed Web of Science ®Google Scholar
• Gollasch M. Vasodilator signals from perivascular adipose tissue. Br J Pharmacol 2011: published online 12 Apr 2011; doi: 10.1111/j.1476-5381.2011.001430.x.
   Web of Science ®Google Scholar
• Maenhaut N, Van de Voorde J. Regulation of vascular tone by adipocytes. BMC Med 2011;9:25
   PubMed Web of Science ®Google Scholar
• Ding H, Triggle CR. Endothelial dysfunction in diabetes: multiple targets for treatment. Pflugers Arch 2010;459:977-94
   PubMed Web of Science ®Google Scholar
• Auch-Schwelk W, Katusic ZS, Vanhoutte PM. Contractions to oxygen-derived free radicals are augmented in aorta of the spontaneously hypertensive rat. Hypertension 1989;13:859-64
   PubMed Web of Science ®Google Scholar
• Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from l-arginine. Nature 1988;333:664-6
   PubMed Web of Science ®Google Scholar
• Forstermann U. Nitric oxide and oxidative stress in vascular disease. Pflugers Arch 2010;459:923-39
   PubMed Web of Science ®Google Scholar
• Jin RC, Loscalzo J. Vascular nitric oxide: formation and function. J Blood Med 2010;2010:147-62
   PubMedGoogle Scholar
• Liao JK. Endothelium and acute coronary syndromes. Clin Chem 1998;44:1799-808
   PubMed Web of Science ®Google Scholar
• Shimokawa H, Tsutsui M. Nitric oxide synthases in the pathogenesis of cardiovascular disease: lessons from genetically modified mice. Pflugers Arch 2010;459:959-67
   PubMed Web of Science ®Google Scholar
• Saraiva RM, Hare JM. Nitric oxide signaling in the cardiovascular system: implications for heart failure. Curr Opin Cardiol 2006;21:221-8
   PubMed Web of Science ®Google Scholar
• Rudolph V, Freeman BA. Cardiovascular consequences when nitric oxide and lipid signaling converge. Circ Res 2009;105:511-22
   Google Scholar
• Bolotina VM, Najibi S, Palacino JJ, Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 1994;368:850-3
   PubMed Web of Science ®Google Scholar
• Davidge ST, Baker PN, Laughlin MK, Roberts JM. Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase. Circ Res 1995;77:274-83
   PubMed Web of Science ®Google Scholar
• Kamper AM, Paul LC, Blauw GJ. Prostaglandins are involved in acetylcholine- and 5-hydroxytryptamine-induced, nitric oxide-mediated vasodilatation in human forearm. J Cardiovasc Pharmacol 2002;40:922-9
   PubMed Web of Science ®Google Scholar
• Yang C, Kwan YW, Au AL, 14,15-Epoxyeicosatrienoic acid induces vasorelaxation through the prostaglandin EP2 receptors in rat mesenteric artery. Prostaglandins Other Lipid Mediat 2010;93:44-51
   PubMed Web of Science ®Google Scholar
• Miura H, Gutterman DD. Human coronary arteriolar dilation to arachidonic acid depends on cytochrome P-450 monooxygenase and Ca2+-activated K+ channels. Circ Res 1998;83:501-7
   PubMed Web of Science ®Google Scholar
• Zhao W, Zhang J, Lu Y, Wang R. The vasorelaxant effect of H2S as a novel endogenous gaseous K(ATP) channel opener. EMBO J 2001;20:6008-16
   PubMed Web of Science ®Google Scholar
• Cheng Y, Ndisang JF, Tang G, Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats. Am J Physiol Heart Circ Physiol 2004;287:H2316-23
   PubMed Web of Science ®Google Scholar
• Johansen D, Ytrehus K, Baxter GF. Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia-reperfusion injury–Evidence for a role of K ATP channels. Basic Res Cardiol 2006;101:53-60
   PubMed Web of Science ®Google Scholar
• Wang R. Hydrogen sulfide: a new EDRF. Kidney Int 2009;76:700-4
   PubMed Web of Science ®Google Scholar
• Gadalla MM, Snyder SH. Hydrogen sulfide as a gasotransmitter. J Neurochem 2010;113:14-26
   PubMed Web of Science ®Google Scholar
• Versari D, Daghini E, Virdis A, Endothelium-dependent contractions and endothelial dysfunction in human hypertension. Br J Pharmacol 2009;157:527-36
   PubMed Web of Science ®Google Scholar
• Vanhoutte PM, Shimokawa H, Tang EH, Feletou M. Endothelial dysfunction and vascular disease. Acta Physiol (Oxf) 2009;196:193-222
   PubMed Web of Science ®Google Scholar
• Vanhoutte PM, Feletou M, Taddei S. Endothelium-dependent contractions in hypertension. Br J Pharmacol 2005;144:449-58
   PubMed Web of Science ®Google Scholar
• Tang EH, Ku DD, Tipoe GL, Endothelium-dependent contractions occur in the aorta of wild-type and COX2–/– knockout but not COX1–/– knockout mice. J Cardiovasc Pharmacol 2005;46:761-5
   PubMed Web of Science ®Google Scholar
• Feletou M, Tang EH, Vanhoutte PM. Nitric oxide the gatekeeper of endothelial vasomotor control. Front Biosci 2008;13:4198-217
   PubMed Web of Science ®Google Scholar
• Leopold JA, Loscalzo J. Oxidative enzymopathies and vascular disease. Arterioscler Thromb Vasc Biol 2005;25:1332-40
   PubMed Web of Science ®Google Scholar
• Peyton KJ, Ensenat D, Azam MA, Arginase promotes neointima formation in rat injured carotid arteries. Arterioscler Thromb Vasc Biol 2009;29:488-94
   PubMed Web of Science ®Google Scholar
• Cunnington C, Channon KM. Tetrahydrobiopterin: pleiotropic roles in cardiovascular pathophysiology. Heart 2010;96:1872-7
   PubMed Web of Science ®Google Scholar
• Durante W, Johnson FK, Johnson RA. Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol Physiol 2007;34:906-11
   PubMed Web of Science ®Google Scholar
• Valkonen VP, Paiva H, Salonen JT, Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet 2001;358:2127-8
   PubMed Web of Science ®Google Scholar
• Achan V, Broadhead M, Malaki M, Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol 2003;23:1455-9
   PubMed Web of Science ®Google Scholar
• Johnson FK, Johnson RA, Peyton KJ, Durante W. Arginase inhibition restores arteriolar endothelial function in Dahl rats with salt-induced hypertension. Am J Physiol Regul Integr Comp Physiol 2005;288:R1057-62
   Google Scholar
• Wu G, Morris SM Jr. Arginine metabolism: nitric oxide and beyond. Biochem J 1998;336:1-17
   PubMed Web of Science ®Google Scholar
• Durante W. Regulation of L-arginine transport and metabolism in vascular smooth muscle cells. Cell Biochem Biophys 2001;35:19-34
   PubMed Web of Science ®Google Scholar
• Grumbach IM, Chen W, Mertens SA, Harrison DG. A negative feedback mechanism involving nitric oxide and nuclear factor kappa-B modulates endothelial nitric oxide synthase transcription. J Mol Cell Cardiol 2005;39:595-603
   PubMed Web of Science ®Google Scholar
• Elahi MM, Naseem KM, Matata BM. Nitric oxide in blood. The nitrosative-oxidative disequilibrium hypothesis on the pathogenesis of cardiovascular disease. FEBS J 2007;274:906-23
   PubMed Web of Science ®Google Scholar
• Hamilton CA, Brosnan MJ, Al-Benna S, NAD(P)H oxidase inhibition improves endothelial function in rat and human blood vessels. Hypertension 2002;40:755-62
   PubMed Web of Science ®Google Scholar
• Landmesser U, Spiekermann S, Dikalov S, Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase. Circulation 2002;106:3073-8
   PubMed Web of Science ®Google Scholar
• Taniyama Y, Griendling KK. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 2003;42:1075-81
   PubMed Web of Science ®Google Scholar
• Diep QN, Amiri F, Touyz RM, PPARalpha activator effects on Ang II-induced vascular oxidative stress and inflammation. Hypertension 2002;40:866-71
   PubMed Web of Science ®Google Scholar
• Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. Circulation 2003;108:1912-16
   PubMed Web of Science ®Google Scholar
• Stuhlinger MC, Oka RK, Graf EE, Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine. Circulation 2003;108:933-8
   PubMed Web of Science ®Google Scholar
• Hirata Y, Nagata D, Suzuki E, Diagnosis and treatment of endothelial dysfunction in cardiovascular disease. Int Heart J 2010;51:1-6
   PubMed Web of Science ®Google Scholar
• Linder L, Kiowski W, Buhler FR, Luscher TF. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. Circulation 1990;81:1762-7
   PubMed Web of Science ®Google Scholar
• Anderson TJ. Assessment and treatment of endothelial dysfunction in humans. J Am Coll Cardiol 1999;34:631-8
   PubMed Web of Science ®Google Scholar
• Kuvin JT, Patel AR, Sliney KA, Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am Heart J 2003;146:168-74
   PubMed Web of Science ®Google Scholar
• Wilkinson IB, Fuchs SA, Jansen IM, Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens 1998;16:2079-84
   PubMed Web of Science ®Google Scholar
• Schindler TH, Nitzsche EU, Munzel T, Coronary vasoregulation in patients with various risk factors in response to cold pressor testing: contrasting myocardial blood flow responses to short- and long-term vitamin C administration. J Am Coll Cardiol 2003;42:814-22
   PubMed Web of Science ®Google Scholar
• Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003;23:168-75
   PubMed Web of Science ®Google Scholar
• Rabelink TJ, de Boer HC, van Zonneveld AJ. Endothelial activation and circulating markers of endothelial activation in kidney disease. Nat Rev Nephrol 2010;6:404-14
   PubMed Web of Science ®Google Scholar
• Dignat-George F, Boulanger CM. The many faces of endothelial microparticles. Arterioscler Thromb Vasc Biol 2011;31:27-33
   PubMed Web of Science ®Google Scholar
• Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001;104:365-72
   PubMed Web of Science ®Google Scholar
• Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004;109(23 Suppl 1):III27-32
   PubMed Web of Science ®Google Scholar
• Deanfield J, Donald A, Ferri C, Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens 2005;23:7-17
   PubMed Web of Science ®Google Scholar
• Zhang C, Hein TW, Wang W, Upregulation of vascular arginase in hypertension decreases nitric oxide-mediated dilation of coronary arterioles. Hypertension 2004;44:935-43
   PubMed Web of Science ®Google Scholar
• John S, Schmieder RE. Impaired endothelial function in arterial hypertension and hypercholesterolemia: potential mechanisms and differences. J Hypertens 2000;18:363-74
   PubMed Web of Science ®Google Scholar
• Bauersachs J, Schafer A. Endothelial dysfunction in heart failure: mechanisms and therapeutic approaches. Curr Vasc Pharmacol 2004;2:115-24
   PubMed Web of Science ®Google Scholar
• O'Murchu B, Miller VM, Perrella MA, Burnett JC Jr. Increased production of nitric oxide in coronary arteries during congestive heart failure. J Clin Invest 1994;93:165-71
   PubMed Web of Science ®Google Scholar
• Haywood GA, Tsao PS, von der Leyen HE, Expression of inducible nitric oxide synthase in human heart failure. Circulation 1996;93:1087-94
   PubMed Web of Science ®Google Scholar
• Mohri M, Egashira K, Tagawa T, Basal release of nitric oxide is decreased in the coronary circulation in patients with heart failure. Hypertension 1997;30:50-6
   PubMed Web of Science ®Google Scholar
• Bauersachs J, Bouloumie A, Fraccarollo D, Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: role of enhanced vascular superoxide production. Circulation 1999;100:292-8
   PubMed Web of Science ®Google Scholar
• Mollnau H, Wendt M, Szocs K, Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 2002;90:E58-65
   PubMed Web of Science ®Google Scholar
• Meyer B, Mortl D, Strecker K, Flow-mediated vasodilation predicts outcome in patients with chronic heart failure: comparison with B-type natriuretic peptide. J Am Coll Cardiol 2005;46:1011-18
   PubMed Web of Science ®Google Scholar
• Matsumoto T, Kakami M, Noguchi E, Imbalance between endothelium-derived relaxing and contracting factors in mesenteric arteries from aged OLETF rats, a model of Type 2 diabetes. Am J Physiol Heart Circ Physiol 2007;293:H1480-90
   PubMed Web of Science ®Google Scholar
• Antoniades C, Tousoulis D, Marinou K, Effects of insulin dependence on inflammatory process, thrombotic mechanisms and endothelial function, in patients with type 2 diabetes mellitus and coronary atherosclerosis. Clin Cardiol 2007;30:295-300
   PubMed Web of Science ®Google Scholar
• Shi Y, Vanhoutte PM. Oxidative stress and COX cause hyper-responsiveness in vascular smooth muscle of the femoral artery from diabetic rats. Br J Pharmacol 2008;154:639-51
   PubMed Web of Science ®Google Scholar
• Shi Y, Feletou M, Ku DD, The calcium ionophore A23187 induces endothelium-dependent contractions in femoral arteries from rats with streptozotocin-induced diabetes. Br J Pharmacol 2007;150:624-32
   PubMed Web of Science ®Google Scholar
• Obrosova IG, Drel VR, Oltman CL, Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin-diabetic rats. Am J Physiol Endocrinol Metab 2007;293:E1645-55
   PubMed Web of Science ®Google Scholar
• De Vriese AS, Verbeuren TJ, Van de Voorde J, Endothelial dysfunction in diabetes. Br J Pharmacol 2000;130:963-74
   PubMed Web of Science ®Google Scholar
• Cameron NE, Cotter MA. Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: role of polyol pathway. Diabetologia 1992;35:1011-19
   PubMed Web of Science ®Google Scholar
• Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999;48:1–9
   PubMed Web of Science ®Google Scholar
• MacKenzie A, Cooper EJ, Dowell FJ. Differential effects of glucose on agonist-induced relaxations in human mesenteric and subcutaneous arteries. Br J Pharmacol 2008;153:480-7
   PubMed Web of Science ®Google Scholar
• Janero DR, Lindsley L, Vemuri VK, Makriyannis A. Cannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk. Expert Opin Drug Discov 2011; published online 2 September 2011; doi:10.1517/17460441.2011.608063
   PubMed Web of Science ®Google Scholar
• Meyers MR, Gokce N. Endothelial dysfunction in obesity: etiological role in atherosclerosis. Curr Opin Endocrinol Diabetes Obes 2007;14:365-9
   PubMedGoogle Scholar
• Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006;6:772-83
   PubMed Web of Science ®Google Scholar
• Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004;89:2548-56
   PubMed Web of Science ®Google Scholar
• Rask-Madsen C, King GL. Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes. Nat Clin Pract Endocrinol Metab 2007;3:46-56
   PubMedGoogle Scholar
• Han SH, Quon MJ, Kim JA, Koh KK. Adiponectin and cardiovascular disease: response to therapeutic interventions. J Am Coll Cardiol 2007;49:531-8
   PubMed Web of Science ®Google Scholar
• Silver AE, Beske SD, Christou DD, Overweight and obese humans demonstrate increased vascular endothelial NAD(P)H oxidase-p47(phox) expression and evidence of endothelial oxidative stress. Circulation 2007;115:627-37
   PubMed Web of Science ®Google Scholar
• Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation 2004;109(23 Suppl 1):III39-43
   PubMed Web of Science ®Google Scholar
• Dobarro D, Gomez-Rubin MC, Sanchez-Recalde A, Current pharmacological approach to restore endothelial dysfunction. Cardiovasc Hematol Agents Med Chem 2009;7:212-22
   PubMedGoogle Scholar
• Hornig B, Landmesser U, Kohler C, Comparative effect of ACE inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase. Circulation 2001;103:799-805
   PubMed Web of Science ®Google Scholar
• Siragy HM. Comparing angiotensin II receptor blockers on benefits beyond blood pressure. Adv Ther 2010;27:257-84
   PubMed Web of Science ®Google Scholar
• Hoenicka M, Schmid C. Cardiovascular effects of modulators of soluble guanylyl cyclase activity. Cardiovasc Hematol Agents Med Chem 2008;6:287-301
   PubMedGoogle Scholar
• Janero DR. Nitric oxide (NO)-related pharmaceuticals: contemporary approaches to therapeutic NO modulation. Free Radic Biol Med 2000;28:1495-506
   PubMed Web of Science ®Google Scholar
• Houston MC. The role of cellular micronutrient analysis, nutraceuticals, vitamins, antioxidants and minerals in the prevention and treatment of hypertension and cardiovascular disease. Ther Adv Cardiovasc Dis 2010;4:165-83
   PubMedGoogle Scholar
• Wohlfart P, Xu H, Endlich A, Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (eNOS) expression and preventing eNOS uncoupling. J Pharmacol Exp Ther 2008;325:370-9
   PubMed Web of Science ®Google Scholar
• Yang Q, Xue HM, Wong WT, AVE3085, an enhancer of endothelial nitric oxide synthase, restores endothelial function and reduces blood pressure in spontaneously hypertensive rats. Br J Pharmacol 2011;163:1078-85
   PubMed Web of Science ®Google Scholar
• Frantz S, Adamek A, Fraccarollo D, The eNOS enhancer AVE 9488: a novel cardioprotectant against ischemia reperfusion injury. Basic Res Cardiol 2009;104:773-9
   PubMed Web of Science ®Google Scholar
• Cheang WS, Wong WT, Tian XY, Endothelial nitric oxide synthase enhancer reduces oxidative stress and restores endothelial function in db/db mice. Cardiovasc Res 2011; published online 29 August 2011; doi: 10.1093/cvr/cvr233
   PubMed Web of Science ®Google Scholar
• Ma XL, Tsao PS, Lefer AM. Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion. J Clin Invest 1991;88:1237-43
   PubMed Web of Science ®Google Scholar
• Kenny D, Coughlan MG, Pagel PS, Transforming growth factor beta1 preserves endothelial function after multiple brief coronary artery occlusions and reperfusion. Am Heart J 1994;127:1456-61
   PubMed Web of Science ®Google Scholar
• Schwartz EA, Reaven E, Topper JN, Tsao PS. Transforming growth factor-beta receptors localize to caveolae and regulate endothelial nitric oxide synthase in normal human endothelial cells. Biochem J 2005;390:199-206
   PubMed Web of Science ®Google Scholar
• Walshe TE, Dole VS, Maharaj AS, Inhibition of VEGF or TGF-beta signaling activates endothelium and increases leukocyte rolling. Arterioscler Thromb Vasc Biol 2009;29:1185-92
   PubMed Web of Science ®Google Scholar
• Hauer AD, van Puijvelde GH, Peterse N, Vaccination against VEGFR2 attenuates initiation and progression of atherosclerosis. Arterioscler Thromb Vasc Biol 2007;27:2050-7
   PubMed Web of Science ®Google Scholar
• van Puijvelde GH, van Es T, Habets KL, A vaccine against atherosclerosis: myth or reality? Future Cardiol 2008;4:125-33
   PubMedGoogle Scholar
• Hauer AD, Uyttenhove C, de Vos P, Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis. Circulation 2005;112:1054-62
   PubMed Web of Science ®Google Scholar
• Gaofu Q, Jun L, Xin Y, Vaccinating rabbits with a cholesteryl ester transfer protein (CETP) B-Cell epitope carried by heat shock protein-65 (HSP65) for inducing anti-CETP antibodies and reducing aortic lesions in vivo. J Cardiovasc Pharmacol 2005;45:591-8
   PubMed Web of Science ®Google Scholar
• Hill JM, Zalos G, Halcox JP, Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348:593-600
   PubMed Web of Science ®Google Scholar
• Luttun A, Carmeliet G, Carmeliet P. Vascular progenitors: from biology to treatment. Trends Cardiovasc Med 2002;12:88-96
   PubMed Web of Science ®Google Scholar
• Kawamoto A, Asahara T. Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies. Catheter Cardiovasc Interv 2007;70:477-84
   PubMed Web of Science ®Google Scholar
• Tateishi-Yuyama E, Matsubara H, Murohara T, Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002;360:427-35
   PubMed Web of Science ®Google Scholar
• Sieveking DP, Ng MK. Cell therapies for therapeutic angiogenesis: back to the bench. Vasc Med 2009;14:153-66
   PubMed Web of Science ®Google Scholar
• Rehman J, Li J, Orschell CM, March KL. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003;107:1164-9
   PubMed Web of Science ®Google Scholar
• Yoon CH, Hur J, Park KW, Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 2005;112:1618-27
   PubMed Web of Science ®Google Scholar
• Silvestre JS, Levy BI. Circulating progenitor cells and cardiovascular outcomes: latest evidence on angiotensin-converting enzyme inhibitors. Eur Heart J Suppl 2009;11(Suppl E):E17-21
   Google Scholar
• Kong D, Melo LG, Gnecchi M, Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation 2004;110:2039-46
   PubMed Web of Science ®Google Scholar
• Kalka C, Masuda H, Takahashi T, Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000;97:3422-7
   PubMed Web of Science ®Google Scholar
• Hristov M, Erl W, Weber PC. Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol 2003;23:1185-9
   PubMed Web of Science ®Google Scholar
• Masuda H, Asahara T. Post-natal endothelial progenitor cells for neovascularization in tissue regeneration. Cardiovasc Res 2003;58:390-8
   PubMed Web of Science ®Google Scholar
• Melo LG, Gnecchi M, Pachori AS, Endothelium-targeted gene and cell-based therapies for cardiovascular disease. Arterioscler Thromb Vasc Biol 2004;24:1761-74
   PubMed Web of Science ®Google Scholar
• Cooke JP. The endothelium: a new target for therapy. Vasc Med 2000;5:49-53
   PubMed Web of Science ®Google Scholar
• Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 2003;108:457-63
   PubMed Web of Science ®Google Scholar
• Shintani S, Murohara T, Ikeda H, Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001;103:2776-9
   PubMed Web of Science ®Google Scholar
• Fuchs S, Baffour R, Zhou YF, Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol 2001;37:1726-32
   PubMed Web of Science ®Google Scholar
• Naruse K, Hamada Y, Nakashima E, Therapeutic neovascularization using cord blood-derived endothelial progenitor cells for diabetic neuropathy. Diabetes 2005;54:1823-8
   PubMed Web of Science ®Google Scholar
• Wang XX, Zhang FR, Shang YP, Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial. J Am Coll Cardiol 2007;49:1566-71
   PubMed Web of Science ®Google Scholar
• Albiero M, Menegazzo L, Avogaro A, Fadini GP. Pharmacologic targeting of endothelial progenitor cells. Cardiovasc Hematol Disord Drug Targets 2010;10:16-32
   PubMedGoogle Scholar
• Muro S, Garnacho C, Champion JA, Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. Mol Ther 2008;16:1450-8
   PubMed Web of Science ®Google Scholar
• Ding BS, Dziubla T, Shuvaev VV, Advanced drug delivery systems that target the vascular endothelium. Mol Interv 2006;6:98-112
   PubMed Web of Science ®Google Scholar
• Qian HS, Channon K, Neplioueva V, Improved adenoviral vector for vascular gene therapy : beneficial effects on vascular function and inflammation. Circ Res 2001;88:911-17
   PubMed Web of Science ®Google Scholar
• Ramalingam R, Rafii S, Worgall S, Induction of endogenous genes following infection of human endothelial cells with an E1– E4+ adenovirus gene transfer vector. J Virol 1999;73:10183-90
   PubMed Web of Science ®Google Scholar
• Channon KM, Qian HS, Youngblood SA, Acute host-mediated endothelial injury after adenoviral gene transfer in normal rabbit arteries: impact on transgene expression and endothelial function. Circ Res 1998;82:1253-62
   PubMed Web of Science ®Google Scholar
• Nicklin SA, White SJ, Nicol CG, In vitro and in vivo characterisation of endothelial cell selective adenoviral vectors. J Gene Med 2004;6:300-8
   PubMed Web of Science ®Google Scholar
• White SJ, Nicklin SA, Sawamura T, Baker AH. Identification of peptides that target the endothelial cell-specific LOX-1 receptor. Hypertension 2001;37:449-55
   PubMed Web of Science ®Google Scholar
• Hossen MN, Kajimoto K, Akita H, Ligand-based targeted delivery of a peptide modified nanocarrier to endothelial cells in adipose tissue. J Control Release 2010;147:261-8
   PubMed Web of Science ®Google Scholar
• Predescu D, Vogel SM, Malik AB. Functional and morphological studies of protein transcytosis in continuous endothelia. Am J Physiol Lung Cell Mol Physiol 2004;287:L895-901
   Google Scholar
• Carver LA, Schnitzer JE. Caveolae: mining little caves for new cancer targets. Nat Rev Cancer 2003;3:571-81
   PubMed Web of Science ®Google Scholar
• Trepel M, Grifman M, Weitzman MD, Pasqualini R. Molecular adaptors for vascular-targeted adenoviral gene delivery. Hum Gene Ther 2000;11:1971-81
   PubMed Web of Science ®Google Scholar
• Dalsgaard T, Kroigaard C, Simonsen U. Calcium-activated potassium channels – a therapeutic target for modulating nitric oxide in cardiovascular disease? Expert Opin Ther Targets 2010;14:825-37
   PubMed Web of Science ®Google Scholar
• Nelson MT, Cheng H, Rubart M, Relaxation of arterial smooth muscle by calcium sparks. Science 1995;270:633-7
   PubMed Web of Science ®Google Scholar
• Feletou M. Calcium-activated potassium channels and endothelial dysfunction: therapeutic options? Br J Pharmacol 2009;156:545-62
   PubMed Web of Science ®Google Scholar
• Yang Q, Huang JH, Man YB, Use of intermediate/small conductance calcium-activated potassium-channel activator for endothelial protection. J Thorac Cardiovasc Surg 2011;141:501-10; 10 e1
   PubMed Web of Science ®Google Scholar
• Vang A, Mazer J, Casserly B, Choudhary G. Activation of endothelial BKCa channels causes pulmonary vasodilation. Vascul Pharmacol 2010;53:122-9
   PubMed Web of Science ®Google Scholar
• Marinou K, Tousoulis D, Antonopoulos AS, Obesity and cardiovascular disease: from pathophysiology to risk stratification. Int J Cardiol 2010;138:3-8
   PubMed Web of Science ®Google Scholar
• Lee MY, Tse HF, Siu CW, Genomic changes in regenerated porcine coronary arterial endothelial cells. Arterioscler Thromb Vasc Biol 2007;27:2443-9
   PubMed Web of Science ®Google Scholar
• Wu SM, Chien KR, Mummery C. Origins and fates of cardiovascular progenitor cells. Cell 2008;132:537-43
   PubMed Web of Science ®Google Scholar
• Hans ML, Lowman AM. Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mater Sci 2002;6:319-27
   Web of Science ®Google Scholar